Compass is still being developed and is effectively in beta. Some content and features may be incomplete, change, or not work as expected.

Content is anchored to trusted sources where available, but Compass has not yet been clinically reviewed. It provides general information rather than medical advice.

Feedback helps us identify gaps, errors, usability problems and opportunities to improve Compass over time.

How Compass is developedGive feedback

Loss of microglial TDP-43 caused myelin abnormalities and motor deficits in mice

Original source

Microglial TDP-43 mediates myelin refinement and represses Tyrobp cryptic exon inclusion in mice.Nat Neurosci · 8 July 2026 (opens in a new tab)

Compass summarised this from the study's abstract.

Study details

Studied in
Mouse

Related topics

Removing TDP-43 from microglia in mice caused early myelin abnormalities and later motor deficits. The change impaired microglia’s ability to clear myelin and disrupted Tyrobp messenger RNA, affecting TREM2-DAP12 signaling.

Why this matters

The findings identify a possible mechanism linking microglial TDP-43 loss to impaired myelin maintenance in mice. They do not yet change treatment for people with amyotrophic lateral sclerosis or establish that the same process occurs in humans.

Limitations and context

This was a mechanistic study in genetically modified mice, including early postnatal changes, not a clinical study in people with ALS. The findings still need to be tested in human disease and other models before their relevance to treatment is known.

Summarised by Compass 8 August 2026

This summary was generated by AI from the source listed above. It is not medical advice, so read the original source for anything that affects your care.

Bibliographic data from PubMed is courtesy of the U.S. National Library of Medicine. Compass does not reproduce source abstracts and may not reflect the most current record.

Relevant to you?